Abbott Defends Glucose Monitor Patents In Sinocare Fight
Abbott has denied Sinocare's claims that its patents are invalid and asserted that the use of several screen features provided benefits to device users, accusing its rival once more of selling...To view the full article, register now.
Already a subscriber? Click here to view full article